Abstract
BackgroundThyroid cancer incidence is rising,1 and most thyroid cancer deaths are attributed to a subset of de-differentiated, treatment-refractory, metastatic tumors. Thyroid stimulating hormone receptor (TSHR),2,3 making TSHR a compelling target...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have